Halimi C, Dény P, Gotheil C, Trinchet J C, Mal F, Scavizzi M, Beaugrand M
Service d'Hépato-Gastro-Entérologie, Groupe Hospitalier Universitaire Avicenne-Jean Verdier, France.
Liver. 1991 Dec;11(6):329-33. doi: 10.1111/j.1600-0676.1991.tb00538.x.
Hepatitis C virus (HCV) has been proposed to be a cofactor in the pathogenesis of cirrhosis in patients with chronic alcoholism. The demonstration of a different liver histological pattern in anti-HCV positive patients might provide additional evidence. We studied 164 patients with chronic alcoholism, and histologically proven cirrhosis. For all of them, serum samples were collected at the time of a liver biopsy and stored at -80 degrees C. Testing for anti-HCV antibodies was done using the Ortho Diagnostic Systems Anti-HCV ELISA test. Only reproducible results were considered positive. A semi-quantitative assessment of seven histological parameters was made independently on liver biopsy samples. In the study group, 29 patients (18%) had anti-HCV antibodies. When compared with anti-HCV negative patients, both groups had similar ALT and AST seric activities. Anti-HCV positive patients had a greater score of mononuclear cells infiltrate (0.71 +/- 0.57 vs 0.41 +/- 0.52; p less than 0.05) and a lesser score of alcoholic hepatitis (0.19 +/- 0.57 vs 0.74 +/- 0.74; p less than 0.005). The scores for steatosis, perisinusoidal and perinodular fibrosis, and hepatocellular necrosis were similar in the two groups. In anti-HCV positive patients, with a clearly positive recombinant immunobinding assay (RIBA, Chiron-Ortho Diagnostic Systems), a greater score for hepatic necrosis and a lesser one for fibrosis were demonstrated. Among the seven patients with active cirrhosis, six were anti-HCV positive. Therefore, HCV is likely to play a role in the pathogenesis of liver damage in a few patients with alcoholic cirrhosis, especially, those with active cirrhosis.
丙型肝炎病毒(HCV)被认为是慢性酒精中毒患者肝硬化发病机制中的一个辅助因素。抗HCV阳性患者呈现出不同的肝脏组织学模式,这可能为此提供更多证据。我们研究了164例经组织学证实为肝硬化的慢性酒精中毒患者。对所有患者在肝活检时采集血清样本,并储存于-80℃。使用奥索诊断系统抗HCV ELISA检测法检测抗HCV抗体。仅可重复的结果被视为阳性。对肝活检样本独立进行七个组织学参数的半定量评估。在研究组中,29例患者(18%)抗HCV抗体呈阳性。与抗HCV阴性患者相比,两组的谷丙转氨酶(ALT)和谷草转氨酶(AST)血清活性相似。抗HCV阳性患者的单核细胞浸润评分更高(0.71±0.57 vs 0.41±0.52;p<0.05),酒精性肝炎评分更低(0.19±0.57 vs 0.74±0.74;p<0.005)。两组的脂肪变性、窦周和结节周围纤维化以及肝细胞坏死评分相似。在抗HCV阳性患者中,重组免疫结合试验(RIBA,Chiron - 奥索诊断系统)结果明确为阳性,其肝坏死评分更高,纤维化评分更低。在7例活动性肝硬化患者中,6例抗HCV阳性。因此,HCV可能在少数酒精性肝硬化患者,尤其是活动性肝硬化患者的肝损伤发病机制中起作用。